COV-19 IDx LINKS

For customer support questions related to the COVID-19 PORTAL please contact us at technicalsupport@ipsumdiagnostics.com

* The US Food and Drug Administration on Wednesday, April 1st 2020 granted Emergency Use Authorization (EUA) to Ipsum Diagnostics for the company’s RT-PCR-based SARS-CoV-2 test. The FDA EUA increased our testing capacity processing from 1000 to 4000 tests per day with results in 24 hours.

NEWS & RESOURCES

FDA-EU

Ipsum Diagnostics, LLC, or other laboratories designated by IpsumDiagnostics, LLC that are also certified under the ClinicalLaboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C.§263a, to

Read More »

COVID-19 VIRUS IN OUR SIGHTS

Steven I. Marlowe MD FACP FIDSAMedical Director, Molecular DiagnosticsIpsum Diagnostics Dear Family and Friends — We’re learning more and more about this epidemic as it progresses,

Read More »